AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- PHARMACEUTICAL COST TRANSPARENCY

Directs the state board of pharmacy to annually identify up to fifteen prescription drugs with increased costs and provides the list to the attorney general to obtain reasons for the cost increases.